Oxytocin · Research brief
Oxytocin Price — Research-Grade Peptide Cost Guide
Short answer
The oxytocin price you see listed isn't the full story. In fact, it might be the least important number on the specification sheet. A 2mg vial can range from $35 to $120, and the difference isn't packaging or branding. It's whether the peptide was synthesized using solid-phase peptide synthesis (SPPS) with real-time amino-acid sequencing verification, or bulk-produced with minimal purity…
Key takeaways
- Oxytocin price ranges from $35 to $120 per 2mg vial, with the difference driven by synthesis method, purity grade (95–99%), and third-party verification rather than markup.
- Solid-phase peptide synthesis (SPPS) produces oxytocin with exact amino-acid sequencing and verified disulfide bond formation, critical for reproducible receptor binding in research protocols.
- Reconstituted oxytocin at 98–99% purity remains stable for 28–30 days at 2–8°C, while lower-purity variants often degrade within 14–21 days post-reconstitution.
- The oxytocin price per reliable dose can be lower with a $95 vial that maintains potency for 30 days than a $40 vial that degrades after two weeks.
- Lyophilized oxytocin can tolerate ambient temperature (up to 25°C) for 48–72 hours, but temperatures above 30°C during shipping denature the peptide even in solid form.
- Batch-specific HPLC documentation and third-party purity verification add $8–$15 per vial but provide the traceability required for peer-reviewed research and data validity.
The oxytocin price you see listed isn't the full story. In fact, it might be the least important number on the specification sheet. A 2mg vial can range from $35 to $120, and the difference isn't packaging or branding. It's whether the peptide was synthesized using solid-phase peptide synthesis (SPPS) with real-time amino-acid sequencing verification, or bulk-produced with minimal purity testing. One degrades within days of reconstitution. The other maintains structural integrity through a full research cycle.
We've worked with research teams who switched peptide suppliers three times in six months. Not because of oxytocin price, but because inconsistent potency invalidated entire study cohorts. The gap between functional research-grade peptides and commodity-grade imitations comes down to three factors most procurement departments never ask about.
What determines the oxytocin price range for research-grade peptides?
Oxytocin price is determined by synthesis method, purity grade (typically 95–99%), batch size, third-party purity verification (HPLC, mass spectrometry), and supplier quality control standards. Research-grade oxytocin synthesized through small-batch SPPS with exact amino-acid sequencing costs $65–$120 per 2mg vial, while bulk-produced alternatives lacking full purity documentation range from $35–$55. The price reflects whether the peptide will maintain structural integrity and deliver reproducible results across a study protocol. Or degrade unpredictably and compromise data validity.
Yes, you can find oxytocin listed at $35 per vial online. But that pricing typically signals bulk synthesis without per-batch HPLC verification, meaning purity could range anywhere from 85% to claimed levels with no traceability. The oxytocin price researchers should focus on isn't the lowest available. It's the cost per reproducible result. This article covers exactly what drives oxytocin price variation, how to evaluate true peptide quality beyond the specification sheet, and what lab teams should expect to pay for research-grade oxytocin that performs consistently.
What Drives Research-Grade Oxytocin Price Variation
The oxytocin price difference between a $40 vial and a $95 vial starts at the synthesis stage. Specifically, whether the peptide is produced through solid-phase peptide synthesis (SPPS) with real-time amino-acid coupling verification or through bulk liquid-phase methods that prioritize volume over precision. SPPS builds the peptide chain one amino acid at a time on a solid resin support, with each coupling step verified before proceeding to the next. This method produces oxytocin with exact sequencing fidelity, meaning every molecule in the batch matches the intended nonapeptide structure (Cys-Tyr-Ile-Gln-Asn-Cys-Pro-Leu-Gly-NH2) with the critical disulfide bond between cysteine residues at positions 1 and 6 intact. Liquid-phase synthesis, by contrast, couples multiple amino acids simultaneously in solution. Faster and cheaper, but with higher rates of sequence errors, incomplete couplings, and structural variants that compromise receptor binding affinity.
Purity grade is the second major oxytocin price factor. Research-grade peptides are typically offered at 95%, 98%, or 99% purity, with each percentage point representing exponential increases in purification complexity and cost. Achieving 99% purity requires multiple rounds of high-performance liquid chromatography (HPLC) to separate the target peptide from synthesis byproducts, truncated sequences, and aggregated molecules. The remaining 1% isn't inert filler. It's chemically similar peptide fragments that standard assays might not distinguish from the active compound. For receptor-binding studies or behavioral research where dose precision matters, that 1% difference in purity can translate to 10–15% variability in observed effects. Suppliers charging $35–$45 per vial typically offer 90–95% purity with no batch-specific HPLC chromatogram provided. Suppliers at $75–$120 per vial provide 98–99% purity with full documentation.
Batch size and production model also drive oxytocin price. Small-batch synthesis. Producing 50–200 vials per synthesis run. Allows for tighter quality control, immediate testing of each batch, and traceability down to the individual synthesis date and operator. Large-batch production synthesizes thousands of vials at once, reducing per-unit cost but increasing the risk that a single synthesis error affects an entire product line for months before detection. At Real Peptides, every peptide including Oxytocin is crafted through small-batch synthesis with exact amino-acid sequencing, guaranteeing that purity, consistency, and lab reliability are never compromised for volume. Third-party verification adds another $8–$15 per vial to oxytocin price but provides independent confirmation that the peptide matches its label claim. Critical for peer-reviewed research where data validity depends on reagent integrity.
How Oxytocin Price Relates to Storage Stability and Shelf Life
The oxytocin price paid upfront determines not just initial purity but how long that purity lasts once the vial is in your lab. Oxytocin is a nine-amino-acid peptide with a disulfide bond that makes it particularly vulnerable to oxidation, temperature fluctuation, and pH shifts during storage. High-purity oxytocin synthesized with precise disulfide bond formation remains stable at −20°C for 24–36 months in lyophilized (freeze-dried) form. Lower-purity variants or peptides synthesized with incomplete disulfide bonding begin degrading within 12–18 months even under ideal storage conditions, as oxidative damage to the cysteine residues disrupts the structural loop essential for receptor binding.
Once reconstituted with bacteriostatic water or sterile saline, oxytocin stability drops sharply. Research-grade oxytocin at 98–99% purity maintains potency for 28–30 days when stored at 2–8°C in a sealed vial protected from light. Commodity-grade oxytocin at 90–95% purity often shows measurable degradation within 14–21 days post-reconstitution, as incomplete purification leaves residual synthesis byproducts that catalyze peptide breakdown in solution. The practical implication: a $95 vial that remains stable for 30 days post-reconstitution delivers more usable doses per vial than a $40 vial that degrades after two weeks. The effective oxytocin price per reliable injection can actually be lower with the premium product.
Temperature excursions during shipping are where many labs unknowingly lose peptide integrity before the first use. Lyophilized oxytocin can tolerate brief exposure to ambient temperature (up to 25°C for 48–72 hours) without significant degradation, but temperatures above 30°C. Common in summer shipping or unrefrigerated delivery holds. Begin denaturing the peptide even in solid form. Suppliers who ship oxytocin with cold packs and temperature-monitoring strips typically charge $5–$10 more per vial, but that cost ensures the peptide arrives in the same structural state it left the synthesis facility. At Real Peptides, cold chain logistics are non-negotiable. Every research-grade peptide including Thymalin and NAD 100mg ships with temperature-controlled packaging to guarantee stability from synthesis to your lab bench. The oxytocin price you see reflects not just what's in the vial, but how it got there.
Oxytocin Price: Synthesis Method Comparison
Solid-phase peptide synthesis (SPPS) builds oxytocin one amino acid at a time on a solid resin support, with each coupling step verified through ninhydrin or Kaiser tests before proceeding. This method produces oxytocin with exact sequencing fidelity and precise disulfide bond formation between Cys1 and Cys6, critical for receptor binding affinity at the oxytocin receptor (OXTR). SPPS allows for real-time quality control and batch-specific adjustments, but it's labor-intensive and slower. Each synthesis cycle takes 18–24 hours. The resulting oxytocin price for SPPS-produced peptides ranges from $70–$120 per 2mg vial depending on purity grade and supplier.
Liquid-phase synthesis couples amino acids in solution, allowing for faster production and larger batch sizes. This method reduces per-unit oxytocin price to $35–$55 per vial but increases the likelihood of sequence errors, incomplete couplings, and aggregated peptide byproducts. The disulfide bond critical to oxytocin's tertiary structure is harder to control in liquid-phase synthesis, meaning a percentage of molecules in each batch may lack functional receptor-binding capability even if they pass basic purity assays. For research requiring dose precision. Studies measuring oxytocin's effects on social bonding, uterine contraction, or lactation induction. The structural variability introduced by liquid-phase synthesis can confound results.
Recombinant expression in E. coli or yeast is a third synthesis route occasionally used for peptides, but it's rare for oxytocin due to the peptide's small size and the difficulty of ensuring proper disulfide bond formation in bacterial systems. Recombinant oxytocin requires additional purification steps to remove endotoxins and host cell proteins, which can add $15–$25 per vial to production costs while still delivering lower purity than SPPS. Most research-grade oxytocin available in 2026 uses SPPS as the synthesis standard.
| Synthesis Method | Oxytocin Price per 2mg | Typical Purity | Structural Fidelity | Batch Traceability | Bottom Line |
|---|---|---|---|---|---|
| Solid-Phase Peptide Synthesis (SPPS) | $70–$120 | 98–99% | Exact sequencing, verified disulfide bond | Per-batch documentation with HPLC | Highest reproducibility. Required for peer-reviewed research |
| Liquid-Phase Synthesis | $35–$55 | 90–95% | Higher rate of sequence errors, inconsistent disulfide bonding | Limited or no batch-specific testing | Lower cost but higher result variability |
| Recombinant Expression | $60–$90 | 95–97% | Requires endotoxin removal, disulfide bond verification uncertain | Batch-specific endotoxin testing required | Rarely used for oxytocin. More common for larger peptides |
What If: Oxytocin Price Scenarios
What If the Oxytocin Price Seems Too Low Compared to Other Suppliers?
Request a certificate of analysis (COA) with batch-specific HPLC chromatogram and mass spectrometry data before purchasing. Oxytocin priced significantly below market average ($35–$45 per 2mg vial vs $70–$90 industry standard) often indicates bulk liquid-phase synthesis without per-batch purity verification, meaning stated purity could be 10–15 percentage points lower than claimed. Some suppliers list 'peptide content' rather than 'purity' on labels. Peptide content measures total peptide mass including degraded fragments and synthesis byproducts, while purity measures only the intact target molecule. If a supplier cannot provide a recent COA with your specific batch number, the oxytocin price savings come at the cost of result reproducibility.
What If My Lab Budget Requires the Lowest Possible Oxytocin Price?
Prioritize cost per reproducible experiment rather than cost per vial. A $45 vial of 90% purity oxytocin that degrades within two weeks post-reconstitution delivers approximately 8–10 usable research days, while a $85 vial at 98% purity stable for 30 days provides 28 usable days. The higher-priced option costs less per experimental day and eliminates mid-protocol peptide replacement. For labs running multi-week studies, purchasing higher-purity oxytocin upfront reduces the risk of data loss from peptide degradation and the cost of repeating experiments due to inconsistent dosing. Consider consolidating orders to reduce per-vial shipping costs rather than compromising on peptide quality.
What If the Oxytocin Arrives Without Cold Packs or Temperature Monitoring?
Do not use the peptide until the supplier provides confirmation that storage conditions were maintained throughout shipping. Lyophilized oxytocin exposed to temperatures above 30°C for more than 24 hours shows measurable structural degradation even if the powder appears normal. Contact the supplier immediately, request temperature log data if available, and ask for replacement vials shipped with cold chain packaging. Most reputable peptide suppliers including Real Peptides guarantee cold chain logistics and will replace compromised shipments at no cost. The oxytocin price should always include temperature-controlled shipping. If it doesn't, factor replacement risk into your cost analysis.
What If I Need Oxytocin for In Vivo Research Versus In Vitro Studies?
In vivo studies require pharmaceutical-grade or high-purity research-grade oxytocin (98–99% purity minimum) with endotoxin testing documented below 1 EU/mg, as even trace endotoxin contamination can trigger immune responses that confound behavioral or physiological measurements. In vitro receptor-binding assays or cell culture studies can sometimes use 95–97% purity oxytocin at lower oxytocin price points ($55–$75 per vial), since endotoxin effects are less relevant in controlled media environments. However, lower purity still introduces dose variability. A 95% pure solution contains 5% synthesis byproducts that may compete for receptor binding or alter observed EC50 values. For publication-quality data in any research context, 98% purity or higher is the de facto standard.
The Economic Truth About Oxytocin Price
Here's the honest answer: the lowest oxytocin price is almost never the best value. Peptides are not commodity chemicals where generic equivalents perform identically. Oxytocin is a nine-amino-acid molecule with a single disulfide bond that determines whether it binds to OXTR or becomes biologically inert. A $35 vial synthesized through bulk liquid-phase methods without batch-specific HPLC verification is cheaper upfront, but it introduces result variability that no statistical analysis can correct for. You cannot run a power analysis to account for peptide degradation mid-protocol. You cannot adjust for unknown purity when calculating dose-response curves. The cost of a failed experiment. Wasted animal time, unusable data, delayed timelines, repeated studies. Is 10 to 50 times the oxytocin price difference between commodity-grade and research-grade peptides.
The suppliers charging $75–$120 per vial are not overpricing. They are absorbing the cost of small-batch synthesis, per-batch HPLC and mass spec verification, cold chain shipping, and the quality control infrastructure required to produce peptides that perform consistently across research protocols. At Real Peptides, the oxytocin price reflects synthesis precision, purity verification, and cold chain logistics that guarantee lab reliability. Every peptide is crafted with the understanding that your research timeline and data validity depend on reagent integrity. If a supplier's oxytocin price seems unusually low, the cost savings are coming from somewhere. And it's usually synthesis quality, purity testing, or post-synthesis stability. The research community has moved past the assumption that all peptides are equivalent. The oxytocin price you pay determines whether your data is publishable or not.
For labs requiring multiple research compounds, consider peptide stacks or bulk orders that reduce per-vial costs without compromising quality. Options like the Wolverine Peptide Stack or purchasing directly from Real Peptides' full peptide collection provide volume pricing while maintaining the small-batch synthesis standards critical for reproducible results. The goal is not to minimize oxytocin price. It's to maximize research outcome per dollar spent, which requires peptides that deliver consistent potency from the first dose to the last.
If oxytocin price is the primary factor driving your procurement decision, you're optimizing for the wrong variable. Ask instead: what is the cost of compromised data? What is the cost of repeating a six-week study because peptide degradation invalidated the final two weeks? What is the cost of reviewer questions about reagent quality that delay publication by months? Those are the costs that matter. The oxytocin price difference between a $40 vial and a $90 vial is $50. The cost of one failed experiment is easily $5,000 in lost time, materials, and opportunity. Real research-grade quality is not an expense. It is the baseline requirement for data that stands up to peer review and moves your work forward.
Build a pack
Researching more than one compound?
Build a multi-vial pack and the discount applies automatically as you add doses.
Questions
RESEARCH USE ONLY · NOT EVALUATED BY THE FDA